Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer
Mesenchymal stem cells (MSCs) are emerging as vehicles for anti-tumor cytotherapy; however, investigation on its efficacy to target a specific cancer stem cell (CSC) population in non-small cell lung cancer (NSCLC) is lacking. Using assays to evaluate cell proliferation, apoptosis, and gene expressi...
Main Authors: | Kamal Shaik Fakiruddin, Moon Nian Lim, Norshariza Nordin, Rozita Rosli, Zubaidah Zakaria, Syahril Abdullah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1261 |
Similar Items
-
Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
by: Kamal Shaik Fakiruddin, et al.
Published: (2021-10-01) -
Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
by: Shaik M Fakiruddin, Shaik Ahmad Kamal
Published: (2021) -
Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL
by: Adriana G. Quiroz-Reyes, et al.
Published: (2021-07-01) -
Oxaliplatin Enhances the Apoptotic Effect of Mesenchymal Stem Cells, Delivering Soluble TRAIL in Chemoresistant Colorectal Cancer
by: Adriana G Quiroz-Reyes, et al.
Published: (2023-10-01) -
Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions
by: Shamima Akter, et al.
Published: (2023-02-01)